Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Chest|April 30, 2025
The frequency and predictors of pulmonary rehabilitation referrals among patients with pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association RegistryMorgan Bailey, Robert Frantz, Jasleen Minhas, et al.
Journal of the American College of Cardiology|June 25, 2003
Beraprost therapy for pulmonary arterial hypertensionRobyn J Barst, Michael McGoon, Vallerie McLaughlin, et al.
Pulmonary Circulation|May 18, 2019
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implicationsC Gregory Elliott, Eric D Austin, David Badesch, et al.
The European Respiratory Journal|February 20, 2025
A Long-Term Follow-Up Study of Sotatercept for Treatment of Pulmonary Arterial Hypertension: Interim Results of SOTERIAIoana R Preston, David Badesch, Hossein-Ardeschir Ghofrani, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2021
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled TrialRoham T Zamanian, David Badesch, Lorinda Chung, et al.
Heart (British Cardiac Society)|February 14, 2023
Pulmonary artery compliance in different forms of pulmonary hypertensionAmber McCormick, Amita Krishnan, David Badesch, et al.
The European Respiratory Journal|November 27, 2020
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHARMarissa Borgese, David Badesch, Todd Bull, et al.
Annals of the American Thoracic Society|October 21, 2020
Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR)Jeff Min, Rui Feng, David Badesch, et al.
American Heart Journal|August 23, 2006
Temporal trends and drug exposures in pulmonary hypertension: an American experienceAlexander M Walker, David Langleben, James J Korelitz, et al.
Pulmonary Circulation|November 26, 2020
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association RegistryShoaib Fakhri, Kelly Hannon, Kelly Moulden, et al.
Pageof 4